Recent development of gold (I) and gold (III) complexes as therapeutic agents for cancer diseases
Y Lu, X Ma, X Chang, Z Liang, L Lv, M Shan… - Chemical Society …, 2022 - pubs.rsc.org
Metal complexes have demonstrated significant antitumor activities and platinum complexes
are well established in the clinical application of cancer chemotherapy. However, the …
are well established in the clinical application of cancer chemotherapy. However, the …
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
K Engle, G Kumar - European journal of medicinal chemistry, 2022 - Elsevier
Chemotherapy is one of the most common treatments for cancer that uses one or more anti-
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Y Su, B Zhao, L Zhou, Z Zhang, Y Shen, H Lv… - Cancer letters, 2020 - Elsevier
Ferroptosis, a form of regulated cell death, is initiated by oxidative perturbations of the
intracellular microenvironment, which is under the constitutive control of glutathione …
intracellular microenvironment, which is under the constitutive control of glutathione …
Therapeutic strategies to overcome cisplatin resistance in ovarian cancer
M Song, M Cui, K Liu - European journal of medicinal chemistry, 2022 - Elsevier
Ovarian cancer (OC) is one of the most common gynecologic tumors worldwide and one
with the highest mortality. Cisplatin (DDP) is the first platinum-based complex approved by …
with the highest mortality. Cisplatin (DDP) is the first platinum-based complex approved by …
The side effects of platinum-based chemotherapy drugs: a review for chemists
R Oun, YE Moussa, NJ Wheate - Dalton transactions, 2018 - pubs.rsc.org
The platinum-based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in
the treatment of cancer and while they are effective, their use is limited by their severe, dose …
the treatment of cancer and while they are effective, their use is limited by their severe, dose …
Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis
Y Lu, Q Pan, W Gao, Y Pu, B He - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
Platinum-based chemotherapy is widely used to treat various cancers. However, exogenous
platinum is likely to cause severe side effects and drug resistance induced by upregulated …
platinum is likely to cause severe side effects and drug resistance induced by upregulated …
Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics
Acute kidney injury (AKI) is a prevalent and lethal adverse event that severely affects cancer
patients receiving chemotherapy. It is correlated with the collateral damage to renal cells …
patients receiving chemotherapy. It is correlated with the collateral damage to renal cells …
The multifaceted roles of copper in cancer: A trace metal element with dysregulated metabolism, but also a target or a bullet for therapy
Simple Summary Copper is an essential element for human life. However, its redox activity
can be detrimental for the cell that developed highly coordinated pathways to chelate and …
can be detrimental for the cell that developed highly coordinated pathways to chelate and …
New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment
SH Chen, JY Chang - International journal of molecular sciences, 2019 - mdpi.com
Although cisplatin has been a pivotal chemotherapy drug in treating patients with various
types of cancer for decades, drug resistance has been a major clinical impediment. In …
types of cancer for decades, drug resistance has been a major clinical impediment. In …
Colorectal carcinoma: a general overview and future perspectives in colorectal cancer
I Mármol, C Sánchez-de-Diego… - International journal of …, 2017 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer and the fourth most common
cause of cancer-related death. Most cases of CRC are detected in Western countries, with its …
cause of cancer-related death. Most cases of CRC are detected in Western countries, with its …